{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:32:32Z","timestamp":1794645152763,"version":"4.9.1"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Epigenetic inactivation of tumour suppressor microRNAs has been implicated in carcinogenesis. We studied the promoter methylation of <jats:italic>MIR203<\/jats:italic> in eight normal marrow controls, eight multiple myeloma (MM) cell lines, 20 monoclonal gammopathy of undetermined significance (MGUS), 123 diagnostic MM and 19 relapsed MM samples by methylation\u2010specific polymerase chain reaction. Promoter of <jats:italic>MIR203<\/jats:italic> was unmethylated in normal controls but homozygously methylated in 25% MM cell lines. Treatment with 5\u2010Aza\u20102\u2032\u2010deoxycytidine led to promoter demethylation and <jats:italic>MIR203<\/jats:italic> re\u2010expression. Cyclic AMP responsive element binding protein 1 (<jats:italic>CREB1<\/jats:italic>) mRNA was predicted as a <jats:italic>MIR203<\/jats:italic> direct target. Luciferase activity was reduced in constructs carrying wild\u2010type <jats:italic>CREB1<\/jats:italic> 3\u2032UTR upon <jats:italic>MIR203<\/jats:italic> expression but not in those carrying mutant <jats:italic>CREB1<\/jats:italic> 3\u2032UTR. Moreover, restoration of <jats:italic>MIR203<\/jats:italic> led to downregulation of CREB1 protein and inhibition of myeloma cell proliferation. In primary samples, <jats:italic>MIR203<\/jats:italic> methylation occurred in 25\u00b70% MGUS, 23\u00b76% diagnostic MM, and 21\u00b71% relapsed MM samples. In conclusion, <jats:italic>MIR203<\/jats:italic> methylation is disease\u2010specific with reversible gene silencing in MM. <jats:italic>MIR203<\/jats:italic> is a tumour suppressor microRNA inhibiting cellular proliferation by targeting <jats:italic>CREB1<\/jats:italic> mRNA in MM. Comparable occurrence of <jats:italic>MIR203<\/jats:italic> methylation in MGUS and MM at diagnosis or relapse suggested that <jats:italic>MIR203<\/jats:italic> methylation may be an early event in myelomagenesis instead of being acquired during disease progression.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2011.08782.x","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T13:02:55Z","timestamp":1309438975000},"page":"569-578","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Epigenetic silencing of <i>MIR203<\/i> in multiple myeloma"],"prefix":"10.1111","volume":"154","author":[{"given":"Kwan\u2010Yeung","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi\u2010Chiu","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong\u2010Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chor\u2010Sang","family":"Chim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(98)00242-8"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.04.018"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1997"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp058190"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-083600"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0797-260"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.7.2033"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.694"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2007"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404176"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404205"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.048"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgq033"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1840"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp250"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.242"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023075"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1108"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl001"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc746"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)01018-3"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.6.12.4408"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4218"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1858"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.09.005"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11122"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3404"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1798"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.04.020"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.02.018"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/003655201317097209"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019027"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2011.08782.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.08782.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:20:12Z","timestamp":1697394012000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2011.08782.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1365-2141.2011.08782.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08782.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]},"assertion":[{"value":"2011-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}